Efficient variant set mixed model association tests for continuous and binary traits in large-scale whole genome sequencing studies

Han Chen,Jennifer E. Huffman,Jennifer A. Brody,Chaolong Wang,Seunggeun Lee,Zilin Li,Stephanie M. Gogarten,Tamar Sofer,Lawrence F. Bielak,Joshua C. Bis,John Blangero,Russell P. Bowler,Brian E. Cade,Michael H. Cho,Adolfo Correa,Joanne E. Curran,Paul S. de Vries,David C. Glahn,Xiuqing Guo,Andrew D. Johnson,Sharon Kardia,Charles Kooperberg,Joshua P. Lewis,Xiaoming Liu,Rasika A. Mathias,Braxton D. Mitchell,Jeffrey R. O’Connell,Patricia A. Peyser,Wendy S. Post,Alex P. Reiner,Stephen S. Rich,Jerome I. Rotter,Edwin K. Silverman,Jennifer A. Smith,Ramachandran S. Vasan,James G. Wilson,Lisa R. Yanek,TOPMed Hematology and Hemostasis Working Group NHLBI Trans-Omics for Precision Medicine Consortium,Susan Redline,Nicholas L. Smith,Eric Boerwinkle,Ingrid B. Borecki,L. Adrienne Cupples,Cathy C. Laurie,Alanna C. Morrison,Kenneth M. Rice,Xihong Lin,
DOI: https://doi.org/10.1101/395046
2018-08-20
Abstract:ABSTRACT With advances in Whole Genome Sequencing (WGS) technology, more advanced statistical methods for testing genetic association with rare variants are being developed. Methods in which variants are grouped for analysis are also known as variant-set, gene-based, and aggregate unit tests. The burden test and Sequence Kernel Association Test (SKAT) are two widely used variant-set tests, which were originally developed for samples of unrelated individuals and later have been extended to family data with known pedigree structures. However, computationally-efficient and powerful variant-set tests are needed to make analyses tractable in large-scale WGS studies with complex study samples. In this paper, we propose the variant-Set Mixed Model Association Tests (SMMAT) for continuous and binary traits using the generalized linear mixed model framework. These tests can be applied to large-scale WGS studies involving samples with population structure and relatedness, such as in the National Heart, Lung, and Blood Institute’s Trans-Omics for Precision Medicine (TOPMed) program. SMMAT tests share the same null model for different variant sets, and a virtue of this null model, which includes covariates only, is that it needs to be only fit once for all tests in each genome-wide analysis. Simulation studies show that all the proposed SMMAT tests correctly control type I error rates for both continuous and binary traits in the presence of population structure and relatedness. We also illustrate our tests in a real data example of analysis of plasma fibrinogen levels in the TOPMed program (n = 23,763), using the Analysis Commons, a cloud-based computing platform.
What problem does this paper attempt to address?